Danske Bank’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
Other funds holding SNOA
Danske Bank's SNOA Position: Q3 2026 in Review
Danske Bank held its Sonoma Pharmaceuticals (SNOA) position steady in Q3 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1155.
Danske Bank first reported a position in SNOA in Q3 2024 and has held it in 9 quarters since. The position peaked at $4 in Q4 2025. 19 funds tracked by Wall St. Rank hold SNOA as of Q3 2026.
- Danske Bank held 1 share of Sonoma Pharmaceuticals worth $1 as of Q3 2026.
- Danske Bank left its Sonoma Pharmaceuticals share count unchanged in Q3 2026.
- Sonoma Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1155 holding.
- Danske Bank first reported a position in Sonoma Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- Danske Bank's Sonoma Pharmaceuticals position peaked at $4 in Q4 2025.
- 19 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.